• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

16,230.0000 JPY 230.0000 1.44%

As of 00:50:24 ET on 12/18/2014.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 16,300.0000 High - Low: 16,420.0000 - 16,230.0000 Primary Exchange: Tokyo
Volume: 307 52-Week Range: 13,840.0000 - 16,930.0000 Beta vs TP17PHRM: 0.9431

ETF Chart for 1621

No chart data available.
  • 1621:JP 16,230.0000
  • 1D
  • 1M
  • 1Y
16,000.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2014-12-17) 15,930.4000
Assets (M) (on 2014-12-17) 662.0000
Shares out (M) 0.04
Market Cap (M) 674.45
% Premium 0.44
Average 52-Week % Premium -0.0606
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 6.57%

Performance for 1621

1-Month -2.91% 1-Year +17.97%
3-Month +3.29% 3-Year +24.19%
Year To Date +14.28% 5-Year +12.69%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 11/28/2014
Name Position Value % of Total
Astellas Pharma Inc 86,842 148,240,000 21.800%
Takeda Pharmaceutical Co Ltd 28,447 141,440,000 20.800%
Otsuka Holdings Co Ltd 15,041 56,440,000 8.300%
Daiichi Sankyo Co Ltd 25,653 44,880,000 6.600%
Eisai Co Ltd 10,068 42,840,000 6.300%
Ono Pharmaceutical Co Ltd 3,480 35,360,000 5.200%
Shionogi & Co Ltd 11,974 35,360,000 5.200%
Chugai Pharmaceutical Co Ltd 7,614 24,480,000 3.600%
Santen Pharmaceutical Co Ltd 2,765 18,360,000 2.700%
Mitsubishi Tanabe Pharma Corp 9,017 16,320,000 2.400%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil